About: http://data.cimple.eu/news-article/566b0066d5f06759bc7d19f4f8f57793e53e40f2558d7b96e0637010

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/566b0066d5f06759bc7d19f4f8f57793e53e40f2558d7b96e0637010 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator. The EIC Accelerator is part of the European Innovation Council (EIC) pilot that supports topclass companies with funding opportunities and acceleration services to help them develop and bring to market innovative products that have high potential to drive economic growth. Novostia aims at improving the quality of life of people suffering from heart valve disease, especially children and young patients, providing them with a unique, durable, anticoagulant-free and silent heart valve prosthesis. "This grant, together with our recent financing round of CHF 6.5 million, will accelerate the development of our technology toward the first in human studies. We appreciate the trust and support from the European Union, our investors, and partners and look forward to bringing this long-awaited innovation to patients and physicians", said Geoffroy Lapeyre, Novostia CEO. About Novostia Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve. For more information, please visit www.novostia.com Caution: Novostia technology is an investigational device not yet approved for sale. View source version on businesswire.com: Contact Geoffroy Lapeyre Chief Executive Officer g.lapeyre@novostia.com © 2020 Business Wire, Inc. Disclaimer: This material is not an AFP editorial material, and AFP shall not bear responsibility for the accuracy of its content. In case you have any questions about the content, kindly refer to the contact person/entity mentioned in the text of the release.
schema:headline	Press Release from Business Wire: Novostia
schema:mentions	Medical device Swiss franc Acceleration Contact (1997 American film) Agence France-Presse Switzerland Chief executive officer United States Silent Heart European Innovation Council Valvular heart disease Artificial heart valve Neuchâtel Julien Louis Geoffroy Framework Programmes for Research and Technological Development Market trend Business Wire
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-01-14 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	80 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software